_version_ 1785090578064605184
author Bazinet, Alexandre
Arani, Naszrin
Chien, Kelly
Hammond, Danielle
Kadia, Tapan
Borthakur, Gautam
Alvarado, Yesid
Sasaki, Koji
Dinardo, Courtney
Pemmaraju, Naveen
Masarova, Lucia
Short, Nicholas
Yilmaz, Musa
Daver, Naval
Jabbour, Elias
Ravandi, Farhad
Kanagal-Shamanna, Rashmi
Pierce, Sherry
Kantarjian, Hagop
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
author_facet Bazinet, Alexandre
Arani, Naszrin
Chien, Kelly
Hammond, Danielle
Kadia, Tapan
Borthakur, Gautam
Alvarado, Yesid
Sasaki, Koji
Dinardo, Courtney
Pemmaraju, Naveen
Masarova, Lucia
Short, Nicholas
Yilmaz, Musa
Daver, Naval
Jabbour, Elias
Ravandi, Farhad
Kanagal-Shamanna, Rashmi
Pierce, Sherry
Kantarjian, Hagop
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
author_sort Bazinet, Alexandre
collection PubMed
description
format Online
Article
Text
id pubmed-10428887
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288872023-08-17 P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS Bazinet, Alexandre Arani, Naszrin Chien, Kelly Hammond, Danielle Kadia, Tapan Borthakur, Gautam Alvarado, Yesid Sasaki, Koji Dinardo, Courtney Pemmaraju, Naveen Masarova, Lucia Short, Nicholas Yilmaz, Musa Daver, Naval Jabbour, Elias Ravandi, Farhad Kanagal-Shamanna, Rashmi Pierce, Sherry Kantarjian, Hagop Garcia-Manero, Guillermo Montalban-Bravo, Guillermo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428887/ http://dx.doi.org/10.1097/01.HS9.0000969848.12543.85 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Bazinet, Alexandre
Arani, Naszrin
Chien, Kelly
Hammond, Danielle
Kadia, Tapan
Borthakur, Gautam
Alvarado, Yesid
Sasaki, Koji
Dinardo, Courtney
Pemmaraju, Naveen
Masarova, Lucia
Short, Nicholas
Yilmaz, Musa
Daver, Naval
Jabbour, Elias
Ravandi, Farhad
Kanagal-Shamanna, Rashmi
Pierce, Sherry
Kantarjian, Hagop
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
title P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
title_full P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
title_fullStr P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
title_full_unstemmed P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
title_short P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
title_sort p736: analysis of response rates and outcomes in erythroid-predominant myelodysplastic syndromes (mds) treated with venetoclax-based regimens
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428887/
http://dx.doi.org/10.1097/01.HS9.0000969848.12543.85
work_keys_str_mv AT bazinetalexandre p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT araninaszrin p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT chienkelly p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT hammonddanielle p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT kadiatapan p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT borthakurgautam p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT alvaradoyesid p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT sasakikoji p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT dinardocourtney p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT pemmarajunaveen p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT masarovalucia p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT shortnicholas p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT yilmazmusa p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT davernaval p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT jabbourelias p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT ravandifarhad p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT kanagalshamannarashmi p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT piercesherry p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT kantarjianhagop p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT garciamaneroguillermo p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens
AT montalbanbravoguillermo p736analysisofresponseratesandoutcomesinerythroidpredominantmyelodysplasticsyndromesmdstreatedwithvenetoclaxbasedregimens